THERANEXUS announces its financial calendar for 2020

20/01/2020
Download PDF File (276Ko)

THERANEXUS announces the clinical results of its phase 1b study demonstrating the extended pharmacological profile of its drug candidate THN201 compared to donepezil

15/01/2020
Download PDF File (381 Ko)